Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.11 +0.05 (+83.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Change in Accured Expenses (2010 - 2026)

Updated

Mosaic ImmunoEngineering (CPMV) posted Change in Accured Expenses of $116,161 for Q1 2026, down 4.2% from $121,297 a year earlier and down 2.5% from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Change in Accured Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Change in Accured Expenses at Mosaic ImmunoEngineering was $481,420, down 11.2% year-over-year; for FY2025, it was $486,556, down 16.5% from FY2024.

  • Annual Change in Accured Expenses has declined for three consecutive years, though with a five-year compound annual growth rate of 4.3% (FY2020 to FY2025).
  • In prior years, Mosaic ImmunoEngineering's Change in Accured Expenses was $582,741 in FY2024 (-25.8%), $785,779 in FY2023 (-22.0%), $1.01 million in FY2022 (+1.0%) and $997,866 in FY2021 (+153.6%).
  • The Q1 2026 figure stands as the lowest quarterly Change in Accured Expenses in data going back to Q1 2021.
  • On a year-over-year basis, Change in Accured Expenses has declined in each of the last 15 quarters, with an average decline of 17.6% over the last eight quarters.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q1 2022, with growth of 15.5%; the weakest was Q4 2024, with a decline of 34.2%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was $119,099 (Q4 2025), $123,111 (Q3 2025) and $123,049 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Mosaic ImmunoEngineering 796,635.07 796,635.07 - 116,161.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 116,161.00
Dec 31, 2025 119,099.00
Sep 30, 2025 123,111.00
Jun 30, 2025 123,049.00
Mar 31, 2025 121,297.00
Dec 31, 2024 125,802.00
Sep 30, 2024 129,373.00
Jun 30, 2024 165,531.00
Mar 31, 2024 162,035.00
Dec 31, 2023 191,118.00
Sep 30, 2023 167,572.00
Jun 30, 2023 204,132.00
Mar 31, 2023 222,957.00
Dec 31, 2022 253,903.00
Sep 30, 2022 241,294.00
Jun 30, 2022 256,782.00
Mar 31, 2022 255,856.00
Dec 31, 2021 270,801.00
Sep 30, 2021 268,918.00
Jun 30, 2021 236,617.00
API Access

Mosaic ImmunoEngineering Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CPMV&period=max&api_key=YOUR_API_KEY